Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Borghi

Showing results (11-20 of 613) with videos related to

Pageof 62
Sort By:
Current Opinion in Nephrology and Hypertension|August 21, 2002
Interactions between hypercholesterolemia and hypertension: implications for therapyClaudio Borghi
Revue Medicale Suisse|June 14, 2006
[Hypertensive patients can benefit from a new generation of calcium channel blockers. Lercanidipine: effective with few side effects]Claudio Borghi
Current Medical Research and Opinion|September 29, 2015
The role of uric acid in the development of cardiovascular diseaseClaudio Borghi
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 11, 2023
Why this special section?Claudio Borghi
Internal and Emergency Medicine|November 24, 2006
Compliance with therapy in hypertensive patientsClaudio Borghi
Current Vascular Pharmacology|December 25, 2012
Hypertension: quo vadis?Claudio Borghi
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 26, 2015
Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical IssuesClaudio Borghi, , Francesco Rossi, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2019
Serum Urate, Uricase, and Blood Pressure Control in GoutClaudio Borghi, Agostino Virdis
European Heart Journal|October 7, 2021
Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data?Claudio Borghi, Giulia Fiorini
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|February 23, 2013
Omega-3 in antiarrhythmic therapy : cons positionClaudio Borghi, Ilenia Pareo
Pageof 62

Showing results (11-20 of 613) with videos related to

Sort By:
Pageof 62
Current Opinion in Nephrology and Hypertension|August 21, 2002
Interactions between hypercholesterolemia and hypertension: implications for therapyClaudio Borghi
Revue Medicale Suisse|June 14, 2006
[Hypertensive patients can benefit from a new generation of calcium channel blockers. Lercanidipine: effective with few side effects]Claudio Borghi
Current Medical Research and Opinion|September 29, 2015
The role of uric acid in the development of cardiovascular diseaseClaudio Borghi
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 11, 2023
Why this special section?Claudio Borghi
Internal and Emergency Medicine|November 24, 2006
Compliance with therapy in hypertensive patientsClaudio Borghi
Current Vascular Pharmacology|December 25, 2012
Hypertension: quo vadis?Claudio Borghi
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 26, 2015
Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical IssuesClaudio Borghi, , Francesco Rossi, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2019
Serum Urate, Uricase, and Blood Pressure Control in GoutClaudio Borghi, Agostino Virdis
European Heart Journal|October 7, 2021
Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data?Claudio Borghi, Giulia Fiorini
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|February 23, 2013
Omega-3 in antiarrhythmic therapy : cons positionClaudio Borghi, Ilenia Pareo
Pageof 62